Cargando…
Genomic and non-genomic actions of glucocorticoids in asthma
Glucocorticoids are the mainstay of asthma therapy. They are primarily used to suppress airway inflammation, which is the central pathological change in asthmatic patients’ airways. This is achieved by many different mechanisms. The classical mechanism is by suppression of the genetic transcription...
Autor principal: | Alangari, Abdullah A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930650/ https://www.ncbi.nlm.nih.gov/pubmed/20835306 http://dx.doi.org/10.4103/1817-1737.65040 |
Ejemplares similares
-
Genomic and Non-Genomic Actions of Glucocorticoids on Adipose Tissue Lipid Metabolism
por: Mir, Negar, et al.
Publicado: (2021) -
Corticosteroids in the treatment of acute asthma
por: Alangari, Abdullah A.
Publicado: (2014) -
Effects of glucocorticoids on leukocytes: Genomic and non-genomic mechanisms
por: Jia, Wan-Yu, et al.
Publicado: (2022) -
Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.
por: van der Velden, V H
Publicado: (1998) -
Admission predictability of children with acute asthma
por: Alherbish, Maan, et al.
Publicado: (2018)